GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » YoY EPS Growth

Godavari Drugs (BOM:530317) YoY EPS Growth : 82.02% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Godavari Drugs's YoY EPS Growth for the quarter that ended in Dec. 2023 was 82.02%.

Godavari Drugs's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₹1.62.


Godavari Drugs YoY EPS Growth Historical Data

The historical data trend for Godavari Drugs's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs YoY EPS Growth Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.45 66.25 106.02 27.19 -27.83

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.72 4.73 -11.48 -0.87 82.02

Godavari Drugs YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Godavari Drugs's YoY EPS Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EPS Growth (A: Mar. 2023 )
=(Earnings per Share (Diluted) (A: Mar. 2023 )-Earnings per Share (Diluted) (A: Mar. 2022 ))/ | Earnings per Share (Diluted) (A: Mar. 2022 ) |
=(5.03-6.97)/ | 6.97 |
=-27.83 %

Godavari Drugs's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(1.62-0.89)/ | 0.89 |
=82.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Godavari Drugs YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines